Versant Ventures

Versant Ventures is a healthcare investment firm founded in 1999 that partners with entrepreneurs to build biotechnology companies. The firm reports $5.5 billion in assets under management, and counts more than 50 portfolio company IPOs and more than 50 acquisitions among its realised outcomes. Its team brings experience across venture capital, pharmaceuticals and biotechnology.

Beyond conventional venture investing, Versant operates Discovery Engines: in-house teams of multidisciplinary scientists, based in laboratory facilities, who work alongside academic founders to launch novel biotechnology companies. Discovery Engine operations are located in San Diego and Basel, supported by academic partnerships intended to feed company creation. The model places the firm upstream of the typical venture process, combining wet-lab execution with the capital formation of a new company.

The firm's footprint spans North America and Europe, with presence in the United States, Canada and Switzerland. Investment activity is concentrated in healthcare, biotechnology and pharmaceuticals, with technical domains including drug discovery and life sciences. The stated approach is to harness science globally, drawing on a network of offices and academic relationships across the two regions.